Related references
Note: Only part of the references are listed.First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial
Maria M. E. Jongsma et al.
GUT (2022)
Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot
Tommaso Lorenzo Parigi et al.
GASTROENTEROLOGY (2021)
Whole exome sequencing analyses reveal gene-microbiota interactions in the context of IBD
Shixian Hu et al.
GUT (2021)
Crohn's Disease Pathobiont Adherent-Invasive E coli Disrupts Epithelial Mitochondrial Networks With Implications for Gut Permeability
Nicole L. Mancini et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)
Exploring the Role of Gut Microbiome in Colon Cancer
Indranil Chattopadhyay et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2021)
Immunoglobulin A Targets a Unique Subset of the Microbiota in Inflammatory Bowel Disease
Jason M. Shapiro et al.
CELL HOST & MICROBE (2021)
Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
Srishti Saha et al.
GASTROENTEROLOGY (2021)
Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues
Mirae Lee et al.
GASTROENTEROLOGY (2021)
Microbiota-Derived Metabolites, Indole-3-aldehyde and Indole-3-acetic Acid, Differentially Modulate Innate Cytokines and Stromal Remodeling Processes Associated with Autoimmune Arthritis
David Langan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?
Sara Deleu et al.
EBIOMEDICINE (2021)
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
Brian G. Feagan et al.
LANCET (2021)
Microbes exploit death-induced nutrient release by gut epithelial cells
Christopher J. Anderson et al.
NATURE (2021)
The role of oral bacteria in inflammatory bowel disease
Emily Read et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
Atsushi Nishida et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Dynamic Colonization of Microbes and Their Functions after Fecal Microbiota Transplantation for Inflammatory Bowel Disease
Nathaniel D. Chu et al.
MBIO (2021)
Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis
Daniel van der Lelie et al.
NATURE COMMUNICATIONS (2021)
Effect of Probiotic Use on Adverse Events in Adult Patients with Inflammatory Bowel Disease: a Retrospective Cohort Study
Maria Pina Dore et al.
PROBIOTICS AND ANTIMICROBIAL PROTEINS (2020)
IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease
Stephen B. Hanauer et al.
JOURNAL OF CROHNS & COLITIS (2020)
Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis
Yonghyun Lee et al.
NATURE MATERIALS (2020)
Scientific frontiers in faecal microbiota transplantation: joint document of Asia-Pacific Association of Gastroenterology (APAGE) and Asia-Pacific Society for Digestive Endoscopy (APSDE)
Siew C. Ng et al.
GUT (2020)
Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review
Rapat Pittayanon et al.
GASTROENTEROLOGY (2020)
Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells
Nick Powell et al.
GUT (2020)
Mitochondrial impairment drives intestinal stem cell transition into dysfunctional Paneth cells predicting Crohn's disease recurrence
Sevana Khaloian et al.
GUT (2020)
Fusobacterium nucleatum facilitates ulcerative colitis through activating IL-17F signaling to NF-κB via the upregulation of CARD3 expression
Yongyu Chen et al.
JOURNAL OF PATHOLOGY (2020)
Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis
Xinyang Song et al.
NATURE (2020)
Gut microbiota-derived metabolites as key actors in inflammatory bowel disease
Aonghus Lavelle et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Growth effects of N-acylethanolamines on gut bacteria reflect altered bacterial abundances in inflammatory bowel disease
Nadine Fornelos et al.
NATURE MICROBIOLOGY (2020)
Interaction Between the Microbiota, Epithelia, and Immune Cells in the Intestine
Hisako Kayama et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells
Clarissa Campbell et al.
NATURE (2020)
A Microbiota-Derived Metabolite Augments Cancer Immunotherapy Responses in Mice
Emma Allen-Vercoe et al.
CANCER CELL (2020)
The Gut Microbiota at the Service of Immunometabolism
Chloe Michaudel et al.
CELL METABOLISM (2020)
Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD
Matthew R. Kudelka et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Fecal Microbiota Alterations Associated With Clinical and Endoscopic Response to Infliximab Therapy in Crohn's Disease
Xiaojun Zhuang et al.
INFLAMMATORY BOWEL DISEASES (2020)
Defined microbiota transplant restores Th17/RORγt+ regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotas
Graham J. Britton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Host-microbiota interactions in inflammatory bowel disease
Roberta Caruso et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Early intervention with faecal microbiota transplantation: an effective means to improve growth performance and the intestinal development of suckling piglets
C. S. Cheng et al.
ANIMAL (2019)
Population-level analysis of Blastocystis subtype prevalence and variation in the human gut microbiota
Raul Y. Tito et al.
GUT (2019)
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Jason Lloyd-Price et al.
NATURE (2019)
Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease
Almut Heinken et al.
MICROBIOME (2019)
Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases
Konrad Aden et al.
GASTROENTEROLOGY (2019)
Maternal IgA protects against the development of necrotizing enterocolitis in preterm infants
Kathyayini P. Gopalakrishna et al.
NATURE MEDICINE (2019)
Microbial genes and pathways in inflammatory bowel disease
Melanie Schirmer et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Inflammatory Bowel Disease: A Stressed Gut/Feeling
Yvonne Oligschlaeger et al.
CELLS (2019)
The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications
Jessica R. Allegretti et al.
LANCET (2019)
Baseline microbiota composition modulates antibiotic-mediated effects on the gut microbiota and host
Aonghus Lavelle et al.
MICROBIOME (2019)
A Listeria monocytogenes Bacteriocin Can Target the Commensal Prevotella copri and Modulate Intestinal Infection
Nathalie Rolhion et al.
CELL HOST & MICROBE (2019)
Bile acid metabolites control TH17 and Treg cell differentiation
Saiyu Hang et al.
NATURE (2019)
Enterotoxigenic Escherichia coli heat labile enterotoxin inhibits intestinal ascorbic acid uptake via a cAMP-dependent NF-κB-mediated pathway
Ganapathy A. Subramenium et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2019)
Mucosal Healing and Bacterial Composition in Response to Enteral Nutrition Vs Steroid-based Induction Therapy-A Randomised Prospective Clinical Trial in Children With Crohn's Disease
Benedicte Pigneur et al.
JOURNAL OF CROHNS & COLITIS (2019)
Gut microbiome structure and metabolic activity in inflammatory bowel disease
Eric A. Franzosa et al.
NATURE MICROBIOLOGY (2019)
Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut
Pichet Praveschotinunt et al.
NATURE COMMUNICATIONS (2019)
Type VI Secretion Systems and the Gut Microbiota
Michael J. Coyne et al.
MICROBIOLOGY SPECTRUM (2019)
Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease
Floris Imhann et al.
GUT (2018)
Card9 mediates susceptibility to intestinal pathogens through microbiota modulation and control of bacterial virulence
Bruno Lamas et al.
GUT (2018)
Adherent-invasive Escherichia coli in inflammatory bowel disease
Carolina Palmela et al.
GUT (2018)
Microbiota-Derived Indole Metabolites Promote Human and Murine Intestinal Homeostasis through Regulation of Interleukin-10 Receptor
Erica E. Alexeev et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
Mark Fleisher et al.
DIGESTIVE DISEASES AND SCIENCES (2018)
The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn's disease
Loris R. Lopetuso et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
Interactions Between Diet and the Intestinal Microbiota Alter Intestinal Permeability and Colitis Severity in Mice
Sean R. Llewellyn et al.
GASTROENTEROLOGY (2018)
Expression of CCR6 and CXCR6 by Gut-Derived CD4+/CD8α+ T-Regulatory Cells, Which Are Decreased in Blood Samples From Patients With Inflammatory Bowel Diseases
Emmanuelle Godefroy et al.
GASTROENTEROLOGY (2018)
Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases
Arie Levine et al.
GUT (2018)
Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease
Alka Goyal et al.
INFLAMMATORY BOWEL DISEASES (2018)
A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease
Pedro Goncalves et al.
INFLAMMATORY BOWEL DISEASES (2018)
Faecalibacterium prausnitzii Produces Butyrate to Maintain Th17/Treg Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 1
Lixing Zhou et al.
INFLAMMATORY BOWEL DISEASES (2018)
Beyond metagenomics, metatranscriptomics illuminates microbiome functionality in IBD
Aonghus Lavelle et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Mitochondrial function - gatekeeper of intestinal epithelial cell homeostasis
Eva Rath et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients
Bahtiyar Yilmaz et al.
PLOS ONE (2018)
NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host-Gut Microbiota Interactions during Inflammatory Bowel Disease
Andrew Leber et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy With Fecal Microbiota Transplantation and Antibiotics
Dai Ishikawa et al.
INFLAMMATORY BOWEL DISEASES (2018)
Precision editing of the gut microbiota ameliorates colitis
Wenhan Zhu et al.
NATURE (2018)
Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis
Jim G. Castellanos et al.
IMMUNITY (2018)
Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome
Arnau Vich Vila et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
A comparative study of the gut microbiota in immune-mediated inflammatory diseasesdoes a common dysbiosis exist?
Jessica D. Forbes et al.
MICROBIOME (2018)
Mechanisms regulating intestinal barrier integrity and its pathological implications
Chaithanya Chelakkot et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases
Betsy W. Stevens et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Interleukin-15 promotes intestinal dysbiosis with butyrate deficiency associated with increased susceptibility to colitis
Marlies Meisel et al.
ISME JOURNAL (2017)
Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis
Atsushi Nishida et al.
JOURNAL OF GASTROENTEROLOGY (2017)
Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches
R. Balfour Sartor et al.
GASTROENTEROLOGY (2017)
Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases
Susanna Nikolaus et al.
GASTROENTEROLOGY (2017)
Intestinal Epithelial Sirtuin 1 Regulates Intestinal Inflammation During Aging in Mice by Altering the Intestinal Microbiota
Alicia S. Wellman et al.
GASTROENTEROLOGY (2017)
Diet as a Trigger or Therapy for Inflammatory Bowel Diseases
James D. Lewis et al.
GASTROENTEROLOGY (2017)
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
Siew C. Ng et al.
LANCET (2017)
Analysis of murine and human Treg subsets in inflammatory bowel disease
Xiaoyun Sun et al.
MOLECULAR MEDICINE REPORTS (2017)
Towards standards for human fecal sample processing in metagenomic studies
Paul I. Costea et al.
NATURE BIOTECHNOLOGY (2017)
Tofacitinib effective in ulcerative colitis
Conor A. Bradley
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation
Koji Atarashi et al.
SCIENCE (2017)
Gut microbiome interactions with drug metabolism, efficacy, and toxicity
Ian D. Wilson et al.
TRANSLATIONAL RESEARCH (2017)
A microbial signature for Crohn's disease
Ayhan Hilmi Cekin
TURKISH JOURNAL OF GASTROENTEROLOGY (2017)
Meta-Analysis of Fecal Microbiota and Metabolites in Experimental Colitic Mice during the Inflammatory and Healing Phases
Toshifumi Osaka et al.
NUTRIENTS (2017)
NLRP6 Protects Il10-/- Mice from Colitis by Limiting Colonization of Akkermansia muciniphila (vol 19, pg 733, 2017)
Sergey S. Seregin et al.
CELL REPORTS (2017)
Distinct Microbial Communities Trigger Colitis Development upon Intestinal Barrier Damage via Innate or Adaptive Immune Cells
Urmi Roy et al.
CELL REPORTS (2017)
A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients
Andrew Brantley Hall et al.
GENOME MEDICINE (2017)
Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease
Ming Zhang et al.
FRONTIERS IN IMMUNOLOGY (2017)
Dynamics of the human gut microbiome in inflammatory bowel disease
Jonas Halfvarson et al.
NATURE MICROBIOLOGY (2017)
Mechanisms of Intestinal Epithelial Barrier Dysfunction by Adherent-Invasive Escherichia coli
Ali Shawki et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2017)
Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn's disease
N. Heerasing et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Role of intestinal microbiota and metabolites on gut homeostasis and human diseases
Lan Lin et al.
BMC IMMUNOLOGY (2017)
Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence
Monika Schaubeck et al.
GUT (2016)
The gut microbiota and host health: a new clinical frontier
Julian R. Marchesi et al.
GUT (2016)
Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice
Thomas W. Hoffmann et al.
ISME JOURNAL (2016)
Gut Virome and Inflammatory Bowel Disease
Loris R. Lopetuso et al.
INFLAMMATORY BOWEL DISEASES (2016)
Accounting for reciprocal host-microbiome interactions in experimental science
Thaddeus S. Stappenbeck et al.
NATURE (2016)
Microcins mediate competition among Enterobacteriaceae in the inflamed gut
Martina Sassone-Corsi et al.
NATURE (2016)
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
B. G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease
Hiutung Chu et al.
SCIENCE (2016)
Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update
Franco Scaldaferri et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Gut Microbiota Diversity and Human Diseases: Should We Reintroduce Key Predators in Our Ecosystem?
Alexis Mosca et al.
FRONTIERS IN MICROBIOLOGY (2016)
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
Paul Moayyedi et al.
GASTROENTEROLOGY (2015)
Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases
Eddy Owaga et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
The fungal microbiota of de-novo paediatric inflammatory bowel disease
I. Mukhopadhya et al.
MICROBES AND INFECTION (2015)
The microbiota regulates type 2 immunity through RORγt+ T cells
Caspar Ohnmacht et al.
SCIENCE (2015)
Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome
Laurence Macia et al.
NATURE COMMUNICATIONS (2015)
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Aleksandar D. Kostic et al.
GASTROENTEROLOGY (2014)
Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis
Ruben J. Colman et al.
JOURNAL OF CROHNS & COLITIS (2014)
Imbalances of CD4+ T-cell subgroups in Crohn's disease and their relationship with disease activity and prognosis
Kang Chao et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
The gut microbiota, bacterial metabolites and colorectal cancer
Petra Louis et al.
NATURE REVIEWS MICROBIOLOGY (2014)
Role of the gut microbiota in human nutrition and metabolism
Balakrishnan S. Ramakrishna
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
The gut microbiota in IBD
Chaysavanh Manichanh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
Raffaella M. Gadaleta et al.
GUT (2011)